BPG is committed to discovery and dissemination of knowledge
Featured Articles
8/10/2022 1:27:53 PM | Browse: 482 | Download: 1723
 |
Received |
|
2022-05-06 10:39 |
 |
Peer-Review Started |
|
2022-05-06 10:40 |
 |
First Decision by Editorial Office Director |
|
2022-06-12 02:55 |
 |
Return for Revision |
|
2022-06-12 02:55 |
 |
Revised |
|
2022-06-19 13:02 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2022-07-19 03:08 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2022-07-22 03:59 |
 |
Articles in Press |
|
2022-07-22 03:59 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2022-08-03 09:19 |
 |
Publish the Manuscript Online |
|
2022-08-10 13:14 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Adjuvant chemoradiotherapy vs adjuvant chemotherapy in locally advanced Siewert type II/III adenocarcinoma of gastroesophageal junction after D2/R0 resection
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wen-Zhe Kang, Jin-Ming Shi, Bing-Zhi Wang, Jian-Ping Xiong, Xin-Xin Shao, Hai-Tao Hu, Jing Jin and Yan-Tao Tian |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82072734 |
|
| Corresponding Author |
Yan-Tao Tian, PhD, Professor, Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China. tianyantao@cicams.ac.cn |
| Key Words |
Siewert type II/III; Gastroesophageal junction; Adjuvant chemoradiotherapy; Adjuvant chemotherapy; Survival; Recurrence |
| Core Tip |
This is a retrospective study to investigate the value of adjuvant chemoradiotherapy (CRT) in locally advanced Siewert type II/III adenocarcinoma of gastroesophageal junction. We identified 316 such patients and followed their overall survival (OS), relapse-free survival, and recurrence pattern. Our study found that for locally advanced Siewert type III gastroesophageal junction, adjuvant CRT may prolong OS and reduce the regional recurrence rate. |
| Publish Date |
2022-08-10 13:14 |
| Citation |
Kang WZ, Shi JM, Wang BZ, Xiong JP, Shao XX, Hu HT, Jin J, Tian YT. Adjuvant chemoradiotherapy vs adjuvant chemotherapy in locally advanced Siewert type II/III adenocarcinoma of gastroesophageal junction after D2/R0 resection. World J Gastrointest Oncol 2022; 14(8): 1540-1551
|
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i8/1540.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i8.1540 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.